Navignostics AG logo — Finding the Right Drug for Each Patient

Navignostics AG

Finding the Right Drug for Each Patient

Founded 2022 Switzerland Horgen, Switzerland 15 employees Seed Total: $8.50M Biotechnology, Health Care +4

General Information

Company Name Navignostics AG
Founded Year 2022
Location Switzerland Horgen, Switzerland +1
Employees 15
Industries Biotechnology, Health Care, Health and Wellness +3
Funding Stage Seed
Social

Get notified when Navignostics AG moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Navignostics AG

Navignostics AG is a Swiss-based biotechnology startup founded in 2022 with the slogan "Finding the Right Drug for Each Patient." The company's mission revolves around identifying the ideal treatment for cancer patients using spatial single-cell proteomics to characterize tumors. This approach enables Navignostics to offer personalized cancer treatment by matching the most effective drug with each patient's specific tumor, ultimately reducing suffering. Additionally, the company's robust technology and advanced data analytics not only facilitate precision cancer diagnostics for patients but also provide valuable insights for the development of companion diagnostics for pharma and biotech partners. The startup recently secured a Fr.7.50M Seed Round investment on 09 November 2022 from notable investors including Ventura BioMed Investors, Zürcher Kantonal Bank, Bruker, and Think.Health. With its focus on revolutionizing cancer treatment through personalized medicine, Navignostics AG aims to make a significant impact by making more drugs available and identifying the right treatment for every patient.

Taxonomy: Precision Medicine, Cancer Treatment, Tumor Characterization, Single-cell Proteomics, Companion Diagnostics, Drug Development, Pharma Partnerships, Biotech Partnerships

Services & Products

tumor analysis
biomarker identification
drug targeting

Target Customers

clinicians researchers drug developers

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 4
Investor
•••• ••••
09 Nov 2022
Convertible Note •••••• 1
Investor
29 Aug 2022

Navignostics AG Alternatives & Competitors

Navignostics AG vs

Elevating personalized chemotherapy for cancer patients with advanced, patient-specific diagnostics...

Convertible Note
2 employees
Biotechnology
Navignostics AG vs

US-based, End-to-End Oncology Pharmacology Solutions CRO

IPO
183 employees
Biotechnology, Health Care
Navignostics AG vs

Personalised Cancer Drug recommendation

3 employees
Health Care

FAQ About Navignostics AG

Finding the Right Drug for Each Patient
Navignostics AG was founded in 2022.
Navignostics AG is headquartered in Horgen, Switzerland.
Navignostics AG operates in the following industries: Biotechnology, Health Care, Health and Wellness, Life Sciences, Medical Devices, Clean Energy.
Navignostics AG has approximately 15 employees.
Navignostics AG has completed 2 funding rounds, raising a total of $8.50M. The latest funding stage is Seed.
Navignostics AG offers: tumor analysis, biomarker identification, drug targeting.
Top alternatives and competitors to Navignostics AG include AccuTheranostics, Inc., Champions Oncology, Inc., My Personal Therapeutics, Epic Sciences, CTCELLS. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Navignostics AG and AccuTheranostics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Navignostics AG and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy